伊拉斯卡制药 ERAS
$14.41 +$1.14 (+8.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.57 +1.11%
开盘$13.42
昨收$13.27
当日区间$13.11 – $14.43
成交量4.03M
市值$5.04B
市盈率（TTM）–
股息率–
ERAS 相关新闻
匹配 Erasca 或代码 ERAS 的头条新闻，按最新排序。
- J.P. Morgan Keeps Their Buy Rating on Erasca (ERAS)
- J.P. Morgan Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $33
- BofA Securities Maintains Erasca(ERAS.US) With Hold Rating, Maintains Target Price $20
- J.P. Morgan Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $33 正面
- J.P. Morgan Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $25 正面
- Stifel Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $30
- Morgan Stanley Maintains Erasca(ERAS.US) With Hold Rating, Maintains Target Price $21
- BofA Securities Maintains Erasca(ERAS.US) With Hold Rating, Raises Target Price to $20 正面
- Guggenheim Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $21 正面
- H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $22 正面
- Piper Sandler Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $22 正面
- Morgan Stanley Maintains Erasca(ERAS.US) With Hold Rating, Raises Target Price to $21 正面
- Jefferies Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $24 正面
- BofA Securities Maintains Erasca(ERAS.US) With Hold Rating, Raises Target Price to $18 正面
- Guggenheim Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $20
暂无评论——快来第一个聊聊 ERAS。
登录后参与讨论。